Dr. Reddy's Laboratories informs about press release

04 Sep 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 4th September titled ‘Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)’.

The above information is a part of company’s filings submitted to BSE.


Dr. Reddys Lab Share Price

1196.60 -27.70 (-2.26%)
29-Jan-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1591.60
Dr. Reddys Lab 1196.60
Cipla 1312.10
Zydus Lifesciences 885.60
Lupin 2103.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×